AbbVie hit with $140 million verdict in AndroGel trial: lawyer

(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in an emailed statement.

from Reuters: U.S. http://ift.tt/2y4mdpe